Hrt Financial LP Nautilus Biotechnology, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.13 $70,652 - $112,827	-36,047 Reduced 58.78%	25,278 $53,000
Q2 2022 Aug 12, 2022	SELL	$2.64 - $4.84 $131,559 - $241,191	-49,833 Reduced 44.83%	61,325 $164,000
Q1 2022 May 16, 2022	BUY	$3.5 - $5.3 $389,053 - $589,137	111,158 New	111,158 $482,000
Q3 2021 Nov 15, 2021	SELL	$6.14 - $10.1 $263,154 - $432,875	-42,859 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.04 - $14.19 $387,445 - $608,169	42,859 New	42,859 $432,000

63.9M

2.9K

500

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $324M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.